

Pharmaco-therapeutic group: Adaptogenic agent
Trekrezan - immunomodulatory drug with pronounced adaptogenic properties. The drug stimulates the production of α- and γ-interferon, contributes to the increase and correction of the immune status of the body due to the activation of cellular and humoral immunity, stimulates the phagocytic activity of macrophages.
The drug strengthens the immune system of the body, increases endurance during physical and mental stress, reduces the effect of various toxins, increases the body's resistance to hypoxia, low and high temperatures and other adverse environmental factors.
The drug has a pronounced anti-toxic effect in case of poisoning with ethanol, organic solvents, salts of heavy metals.
Trekrezan apply:
- to improve immunity (prevention and treatment of colds, flu, ARVI and other viral and bacterial diseases);
- to increase the physical, mental performance and prevention of fatigue, increase the body's resistance to various stressors (hypoxia, overheating, hypothermia);
- in case of secondary immunodeficiency states, incl. against the background of long-term antibiotic therapy;
- as part of complex therapy in case of poisoning with heavy metal salts;
- as part of the treatment of alcohol withdrawal syndrome.
Inside
Forimprove immunity and prevent colds adults and children over 12 years old - 0.2 g / day for 7-14 days.
ATperiod of treatment of a cold, flu, ORVI adults and children over 12 years old - on the first day, 0.6 g / day, then daily at 0.2 g / day in a course for 7 days.
Forincrease physical and mental performance and enhance body resistance to various stressors - on the first day, 0.6 g / day, then daily at 0.2 g / day in a course for 7 days.
Atpoisoning with heavy metal salts - at 0.4-0.6 g / day daily for at least 5 days.
Forreduce the manifestations of alcohol withdrawal syndrome - at 0.4-0.6 g / daily for 5 days.
If necessary, treatment is repeated at intervals of 1-2 months between courses.
ATrare cases allergic reactions.
- Hypersensitivity to any of the components of the drug;
- children up to 12 years (due to the lack of data on the efficacy and safety of use);
- pregnancy;
- lactation period;
- hereditary lactose intolerance;
- Lactase deficiency or impaired absorption of glucose and galactose.
The drug is contraindicated in pregnancy and lactation.
Symptoms of intoxication due to overdose of drugs are not marked.
Undesirable interactions with other drugs are not observed.
Store in a dry, dark place, out of reach of children. Shelf life - 2 years. Do not apply after the expiration date.